يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"Leishmaniasis, Cutaneous drug therapy"', وقت الاستعلام: 1.01s تنقيح النتائج
  1. 1
  2. 2

    المصدر: PLoS Neglected Tropical Diseases, Vol 14, Iss 2, p e0007996 (2020)
    PLoS Neglected Tropical Diseases

  3. 3

    المساهمون: Laboratoire de Transmission, Contrôle et Immunobiologie des Infections - Laboratory of Transmission, Control and Immunobiology of Infection (LR11IPT02), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Université de Tunis El Manar (UTM), École Nationale d'Ingénieurs de Sfax | National School of Engineers of Sfax (ENIS), This work received financial support from the Tunisian Ministry of Higher Education and Scientific Research to the Transmission, Control and Immunobiology of Infections Laboratory (LR11IPT02, D. Laouini)., We thank Mr A. Marouani and Dr Z. Ben Lasfer (Animal Facilities of the Institut Pasteur de Tunis) for their help conducting this study. We are also grateful to Ms S. Amouri for her help and thankful to Dr K. Ben-Aissa (Washignton, USA) and Dr S. Gritli (Department of Oto-Rhino-Laryngology, Charles Nicolle Hospital, Tunis, Tunisia) for their critical reading and grammar corrections

    المصدر: Parasitology
    Parasitology, Cambridge University Press (CUP), 2016, 143 (12), pp.1615-1620. ⟨10.1017/S0031182016001086⟩

  4. 4

    المصدر: Repositorio UdeA
    Universidad de Antioquia
    instacron:Universidad de Antioquia
    PLoS Neglected Tropical Diseases
    PLoS Neglected Tropical Diseases, Vol 12, Iss 7, p e0006653 (2018)

    وصف الملف: application/pdf

  5. 5

    المصدر: Scientific Reports
    Scientific reports, vol. 6, pp. 33458

    وصف الملف: application/pdf

  6. 6

    المساهمون: Ege Üniversitesi, WHO-TDR Suisse, WHO-TDR Suisse-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Nuffield Department of Clinical Medicine [Oxford], University of Oxford [Oxford], U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Drugs for Neglected Diseases initiative Latin America (DNDi), Drugs for Neglected Diseases Initiative, Fundação Oswaldo Cruz (FIOCRUZ), Réseau International des Instituts Pasteur (RIIP), Direction de l’Epidémiologie et de Lutte contre les Maladies (DELM), Université Polytechnique de Bobo-Dioulasso (UPB), University of Gondar - Université de Gondar, Fiocruz Minas - René Rachou Research Center / Instituto René Rachou [Belo Horizonte, Brésil], Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Nuffield Department of Medicine [Oxford, UK] (Big Data Institute), Armauer Hansen Research Institute (AHRI), Shiraz University (Shiraz University ), Tehran University of Medical Sciences (TUMS), Instituto de Medicina Tropical 'Alexander von Humboldt' (IMT AvH), Universidad Peruana Cayetano Heredia (UPCH), Universidad de Antioquia = University of Antioquia [Medellín, Colombia], World Health Organisation (WHO), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), University of Mohammed V, Hôpital La Rabta [Tunis], National Malaria & Leishmaniasis Control Program [Kabul] (NMLCP), Laboratoire d'Epidémiologie Médicale, Institut Pasteur de Tunis, Institut Pasteur de Tunis, Ege university, Instituto Conmemorativo Gorgas de Estudios de la Salud [Panamá], Universidad del Valle de Guatemala, Universidade de Brasilia [Brasília] (UnB), Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM), Fundación Nacional de Dermatología [Santa Cruz] (FUNDERMA), Akdeniz University, Imam Reza Hospital [Iran], Institute of Tropical Medicine [Antwerp] (ITM), Instituto Medico la Floresta [Caracas]

    المصدر: Repositorio UdeA
    Universidad de Antioquia
    instacron:Universidad de Antioquia
    PLoS Neglected Tropical Diseases
    PLoS Neglected Tropical Diseases, Public Library of Science, 2018, 12 (1), pp.e0006141. ⟨10.1371/journal.pntd.0006141⟩
    PLoS Neglected Tropical Diseases, Vol 12, Iss 1, p e0006141 (2018)

    مصطلحات موضوعية: Species Delimitation, Standardization, Speciation, [SDV]Life Sciences [q-bio], Terapéutica, Psychological intervention, Iran, Pathology and Laboratory Medicine, Geographical locations, MESH: Antiprotozoal Agents/therapeutic use, 0302 clinical medicine, Zoonoses, Medicine and Health Sciences, Medicine, 030212 general & internal medicine, Amphotericin, Leishmaniasis, MESH: Treatment Outcome, Protozoans, Ulcers, Leishmania, Clinical Trials as Topic, Pharmaceutics, Antimicrobials, lcsh:Public aspects of medicine, Eukaryota, Drugs, MESH: Leishmaniasis, Cutaneous/drug therapy, 3. Good health, Treatment Outcome, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Infectious Diseases, Systematic review, Ensayos Clínicos como Asunto, Drug therapy, Clinical evaluation, Brazil, purl.org/pe-repo/ocde/ford#3.03.06 [https], Research Article, Neglected Tropical Diseases, medicine.medical_specialty, Evolutionary Processes, lcsh:Arctic medicine. Tropical medicine, lcsh:RC955-962, 030231 tropical medicine, Antiprotozoal Agents, Leishmaniasis, Cutaneous, Standardized test, Mycology, Therapeutics, Microbiology, 03 medical and health sciences, Signs and Symptoms, Drug Therapy, Cutaneous leishmaniasis, Diagnostic Medicine, Microbial Control, Parasitic Diseases, Species delimitation, Humans, Medical physics, Pharmacology, Evolutionary Biology, Antifungals, Protozoan Infections, MESH: Humans, business.industry, Organisms, Public Health, Environmental and Occupational Health, Biology and Life Sciences, lcsh:RA1-1270, South America, Tropical Diseases, medicine.disease, Parasitic Protozoans, Clinical trial, Leishmaniasis Cutánea, Clinical research, Lesions, MESH: Clinical Trials as Topic/standards, People and places, business

    وصف الملف: application/pdf

  7. 7

    المصدر: Infection and immunity
    Infection and Immunity, Vol. 77, No 5 (2009) pp. 2022-9

  8. 8

    المصدر: Clinical Infectious Diseases, Vol. 46, No 2 (2008) pp. 223-31

  9. 9

    المساهمون: Universidad Peruana Cayetano Heredia (UPCH), Pharmacochimie et Biologie pour le Développement (PHARMA-DEV), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)

    المصدر: Planta Medica
    Planta Medica, 2014, 80 (11), pp.902-906. ⟨10.1055/s-0034-1382826⟩
    Planta Medica, Georg Thieme Verlag, 2014, 80 (11), pp.902-906. ⟨10.1055/s-0034-1382826⟩

    مصطلحات موضوعية: benzo[c]phenanthridines, Zanthoxylum, Phenanthridines/chemistry/isolation & purification/pharmacology, Plant Extracts/chemistry/isolation & purification/pharmacology, [SDV]Life Sciences [q-bio], Pharmaceutical Science, leishmanicidal, Benzophenanthridines/chemistry/isolation & purification/pharmacology, Plant Bark/chemistry, Plant Roots, Analytical Chemistry, chemistry.chemical_compound, Mice, Macrophages/drug effects, Zanthoxylum rhoifolium, Parasitic Sensitivity Tests, Drug Discovery, Axenic, Leishmaniasis, Leishmania, Mice, Inbred BALB C, biology, in vitro, Benzo[c]phenanthridines, 3. Good health, Phenanthridines, purl.org/pe-repo/ocde/ford#1.04.01 [https], in vivo, Plant Bark, Molecular Medicine, Female, Cell Survival/drug effects, Stereochemistry, Cell Survival, purl.org/pe-repo/ocde/ford#1.06.03 [https], Leishmaniasis, Cutaneous, Inhibitory Concentration 50, Cutaneous leishmaniasis, In vitro, In vivo, medicine, Animals, Humans, purl.org/pe-repo/ocde/ford#3.01.05 [https], Leishmaniasis, Cutaneous/drug therapy/parasitology, Amastigote, purl.org/pe-repo/ocde/ford#1.04.07 [https], leishmaniasis, Rutaceae, Pharmacology, Benzophenanthridines, Plant Roots/chemistry, Plants, Medicinal, Plant Extracts, Macrophages, Organic Chemistry, Leishmania/drug effects, medicine.disease, biology.organism_classification, Molecular biology, Zanthoxylum/chemistry, Disease Models, Animal, Chelerythrine, Complementary and alternative medicine, chemistry, Leishmania amazonensis

  10. 10

    المساهمون: Institut Pasteur de la Guyane, Réseau International des Instituts Pasteur (RIIP), Department of Biochemistry (WHO-IRTC), Université de Lausanne (UNIL), Institut Guyanais de Dermatologie Tropicale, Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française]

    المصدر: Journal of Infectious Diseases
    Journal of Infectious Diseases, Oxford University Press (OUP), 2009, 199 (4), pp.576-9. ⟨10.1086/596508⟩
    The Journal of Infectious Diseases, vol. 199, no. 4, pp. 576-579

    مصطلحات موضوعية: Male, MESH: Interleukin-10, MESH: Treatment Failure, T-Lymphocytes, Regulatory, Immunology and Allergy, MESH: Animals, Treatment Failure, Leishmania guyanensis, 0303 health sciences, MESH: Middle Aged, FOXP3, Forkhead Transcription Factors, Middle Aged, MESH: Gene Expression Regulation, 3. Good health, Interleukin-10, Interleukin 10, Infectious Diseases, MESH: Pentamidine, Female, medicine.symptom, medicine.drug, Adult, Pentamidine Isethionate, Adolescent, MESH: Leishmania guyanensis, Antiprotozoal Agents, Leishmaniasis, Cutaneous, Animals, Antiprotozoal Agents/therapeutic use, Forkhead Transcription Factors/genetics, Forkhead Transcription Factors/metabolism, Gene Expression Regulation, Humans, Interleukin-10/genetics, Interleukin-10/metabolism, Leishmania guyanensis/drug effects, Leishmaniasis, Cutaneous/drug therapy, Leishmaniasis, Cutaneous/immunology, Pentamidine/therapeutic use, RNA, Messenger/genetics, RNA, Messenger/metabolism, T-Lymphocytes, Regulatory/immunology, T-Lymphocytes, Regulatory/metabolism, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Biology, Lesion, 03 medical and health sciences, Pharmacotherapy, MESH: Forkhead Transcription Factors, medicine, RNA, Messenger, MESH: Antiprotozoal Agents, Pentamidine, 030304 developmental biology, MESH: RNA, Messenger, MESH: Adolescent, MESH: Humans, 030306 microbiology, MESH: T-Lymphocytes, Regulatory, Leishmaniasis, MESH: Adult, medicine.disease, MESH: Leishmaniasis, Cutaneous, MESH: Male, Immunology, MESH: Female

    وصف الملف: application/pdf